vs
Side-by-side financial comparison of Sunshine Biopharma Inc. (SBFM) and Soluna Holdings, Inc (SLNH). Click either name above to swap in a different company.
Sunshine Biopharma Inc. is the larger business by last-quarter revenue ($8.6M vs $8.4M, roughly 1.0× Soluna Holdings, Inc). Sunshine Biopharma Inc. runs the higher net margin — -25.0% vs -284.7%, a 259.7% gap on every dollar of revenue. On growth, Soluna Holdings, Inc posted the faster year-over-year revenue change (11.8% vs -10.6%). Sunshine Biopharma Inc. produced more free cash flow last quarter ($-1.6M vs $-6.8M). Over the past eight quarters, Sunshine Biopharma Inc.'s revenue compounded faster (6.6% CAGR vs -8.8%).
Sunshine Biopharma Inc. is a clinical-stage biopharmaceutical company focused on researching, developing and commercializing innovative therapies for oncology, neurodegenerative disorders and infectious diseases. It targets unmet medical needs across global markets, with a pipeline of targeted therapeutic candidates designed to improve patient treatment outcomes.
SBFM vs SLNH — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.6M | $8.4M |
| Net Profit | $-2.1M | $-24.0M |
| Gross Margin | 35.3% | 9.5% |
| Operating Margin | -20.9% | -92.5% |
| Net Margin | -25.0% | -284.7% |
| Revenue YoY | -10.6% | 11.8% |
| Net Profit YoY | 0.8% | -233.2% |
| EPS (diluted) | — | $-1.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.6M | — | ||
| Q3 25 | $9.4M | $8.4M | ||
| Q2 25 | $9.4M | $6.2M | ||
| Q1 25 | $8.9M | $5.9M | ||
| Q4 24 | $9.6M | $8.3M | ||
| Q3 24 | $8.4M | $7.5M | ||
| Q2 24 | $9.3M | $9.7M | ||
| Q1 24 | $7.5M | $12.5M |
| Q4 25 | $-2.1M | — | ||
| Q3 25 | $-883.8K | $-24.0M | ||
| Q2 25 | $-1.8M | $-7.4M | ||
| Q1 25 | $-1.2M | $-7.6M | ||
| Q4 24 | $-2.2M | $-40.0M | ||
| Q3 24 | $-1.2M | $-7.2M | ||
| Q2 24 | $-494.3K | $-10.9M | ||
| Q1 24 | $-1.3M | $-5.3M |
| Q4 25 | 35.3% | — | ||
| Q3 25 | 32.6% | 9.5% | ||
| Q2 25 | 36.4% | 6.3% | ||
| Q1 25 | 30.7% | 5.7% | ||
| Q4 24 | 32.2% | -360.8% | ||
| Q3 24 | 34.0% | -39.1% | ||
| Q2 24 | 25.3% | 34.6% | ||
| Q1 24 | 31.2% | 45.4% |
| Q4 25 | -20.9% | — | ||
| Q3 25 | -11.5% | -92.5% | ||
| Q2 25 | -21.8% | -107.6% | ||
| Q1 25 | -14.6% | -120.9% | ||
| Q4 24 | -21.7% | -426.0% | ||
| Q3 24 | -13.1% | -119.8% | ||
| Q2 24 | -13.6% | -38.0% | ||
| Q1 24 | -17.9% | 3.2% |
| Q4 25 | -25.0% | — | ||
| Q3 25 | -9.4% | -284.7% | ||
| Q2 25 | -18.8% | -119.9% | ||
| Q1 25 | -13.3% | -127.3% | ||
| Q4 24 | -22.5% | -483.8% | ||
| Q3 24 | -14.2% | -95.5% | ||
| Q2 24 | -5.3% | -112.4% | ||
| Q1 24 | -17.0% | -41.9% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.54 | $-1.14 | ||
| Q2 25 | $-0.82 | $-0.93 | ||
| Q1 25 | $-0.44 | $-1.21 | ||
| Q4 24 | $49.77 | $-7.14 | ||
| Q3 24 | $-11.61 | $-1.56 | ||
| Q2 24 | $-43.48 | $-3.62 | ||
| Q1 24 | $-2.00 | $-2.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | $13.3M |
| Stockholders' EquityBook value | $23.0M | $14.5M |
| Total Assets | $30.1M | $152.0M |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $13.3M | ||
| Q2 25 | — | $10.0M | ||
| Q1 25 | — | $10.2M | ||
| Q4 24 | — | $7.1M | ||
| Q3 24 | — | $8.1M | ||
| Q2 24 | — | $9.0M | ||
| Q1 24 | — | — |
| Q4 25 | $23.0M | — | ||
| Q3 25 | $24.2M | $14.5M | ||
| Q2 25 | $25.7M | $-19.5M | ||
| Q1 25 | $22.7M | $-16.1M | ||
| Q4 24 | $23.5M | $-12.5M | ||
| Q3 24 | $25.0M | $20.9M | ||
| Q2 24 | $23.5M | $24.4M | ||
| Q1 24 | $24.8M | $21.5M |
| Q4 25 | $30.1M | — | ||
| Q3 25 | $31.5M | $152.0M | ||
| Q2 25 | $32.0M | $92.0M | ||
| Q1 25 | $29.2M | $90.0M | ||
| Q4 24 | $30.6M | $88.0M | ||
| Q3 24 | $30.1M | $97.3M | ||
| Q2 24 | $29.3M | $98.7M | ||
| Q1 24 | $31.9M | $90.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.92× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.6M | $-2.2M |
| Free Cash FlowOCF − Capex | $-1.6M | $-6.8M |
| FCF MarginFCF / Revenue | -18.9% | -81.4% |
| Capex IntensityCapex / Revenue | 0.0% | 55.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.5M | $-34.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.6M | — | ||
| Q3 25 | $-727.8K | $-2.2M | ||
| Q2 25 | $-1.3M | $-1.1M | ||
| Q1 25 | $-1.7M | $-177.0K | ||
| Q4 24 | $-3.4M | $-5.1M | ||
| Q3 24 | $-1.4M | $61.0K | ||
| Q2 24 | $-4.6M | $-7.3M | ||
| Q1 24 | $-3.2M | $3.9M |
| Q4 25 | $-1.6M | — | ||
| Q3 25 | $-735.8K | $-6.8M | ||
| Q2 25 | $-1.4M | $-9.7M | ||
| Q1 25 | $-1.7M | $-4.0M | ||
| Q4 24 | $-3.5M | $-13.9M | ||
| Q3 24 | $-1.9M | $-3.4M | ||
| Q2 24 | $-5.6M | $-7.6M | ||
| Q1 24 | $-3.2M | $3.3M |
| Q4 25 | -18.9% | — | ||
| Q3 25 | -7.8% | -81.4% | ||
| Q2 25 | -15.2% | -156.8% | ||
| Q1 25 | -19.3% | -67.1% | ||
| Q4 24 | -36.6% | -168.3% | ||
| Q3 24 | -22.2% | -44.8% | ||
| Q2 24 | -59.7% | -78.2% | ||
| Q1 24 | -43.1% | 26.5% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.1% | 55.2% | ||
| Q2 25 | 1.7% | 139.0% | ||
| Q1 25 | 0.1% | 64.2% | ||
| Q4 24 | 1.1% | 107.0% | ||
| Q3 24 | 6.1% | 45.6% | ||
| Q2 24 | 10.5% | 2.5% | ||
| Q1 24 | 0.8% | 4.2% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SBFM
Segment breakdown not available.
SLNH
| Data Hosting Revenue | $5.3M | 62% |
| Cryptocurrency Mining Revenue | $2.8M | 33% |
| Other | $389.0K | 5% |
